You are here: Industry Insights > DoP

News List

Government imports APIs worth Rs 28,529 crores in FY2020-21 expresspharma
August 05, 2021
The size of the API and Intermediates market in India is estimated to be Rs 96,000 crores in FY 2019-20.
DoP amends Drugs (Prices Control) Order, 2013 expresspharma
July 27, 2021
In the amendment, DoP provided the proforma for a price list for medical devices, which needs to be submitted.
DoP asks NPPA to review, verify Bharat Serum and Vaccine’s request of revising ceiling price of Human Normal Immunoglobulin expresspharma
December 25, 2020
The NPPA has dismissed the company's three contentions except for the applicability of GST.
DoP submits revised PTUAS scheme document to Expenditure Finance Committee expresspharma
December 21, 2020
The Department of Pharmaceuticals (DoP) has submitted the revised Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) to the Expenditure Finance Committee (EFC) for review.
DoP organises meeting with industry associations to discuss implementation of Phase II PLI scheme expresspharma
November 23, 2020
Reportedly, industry associations have jointly submitted their suggestions to the department.
Fall clause does not apply on the sale of drugs which have an expiry date: DoP expresspharma
November 17, 2020
The Department of Pharmaceuticals (DoP) has issued a letter informing the Ministries/Departments involved in the procurement of drugs through agencies that fall clause does not apply on the sale of drugs, which have an expiry date.
DoP forms expert committee to identify investment opportunities, bottlenecks in pharma industry expresspharma
November 06, 2020
The Department of Pharmaceuticals (DoP) has created a six-member expert committee to suggest an action plan for maximum process improvements to attract investments in the pharma sector.
DoP issues letter to pharma associations to ensure adherence to UCPMP expresspharma
November 04, 2020
The department has received a complaint alleging that pharma companies are sponsoring a national level event.
Pharma industry appreciates modification in PLI scheme, seek more support expresspharma
November 02, 2020
The industry also raises concerns related to brownfield investments, protection of indigenous manufacturing.
DoP to launch revised PLI scheme guidelines expresspharma
October 30, 2020
The revised version of PLI scheme may remove minimum investment criteria, include export and sale-based production criteria.

Previous page 1 2 Next page